Evidence map›Paper›PMID 40917895›Full record

ArticleMolecular therapy. Nucleic acids2025

Molecular properties and intramolecular interactions of peptide-conjugated phosphorodiamidate morpholino oligonucleotides.

Evgenii Kliuchnikov, Farkhad Maksudov, Daniel Pierson, Kenneth A Marx, Arani Chanda, Valeri Barsegov

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Evgenii KliuchnikovDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Farkhad MaksudovDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Daniel PiersonTechnical Operations, Sarepta Therapeutics, Cambridge, MA 02142, USA.
Kenneth A MarxDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.
Arani ChandaTechnical Operations, Sarepta Therapeutics, Cambridge, MA 02142, USA.
Valeri BarsegovDepartment of Chemistry, University of Massachusetts, Lowell, MA 01854, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We combined circular dichroism (CD) and viscosity measurements with molecular dynamics (MD) simulations and classification and regression approaches to machine learning to characterize solution structures of 22-mer, 25-mer, and 30-mer peptide- (-GlyArg6) conjugated phosphorodiamidate morpholino oligonucleotides (PPMOs). PPMO molecules form non-canonical folded structures with 1.4- to 1.5-nm radius of gyration, 4-6 base pairs and 5-11 base stacks, characterized by -49 to -71 kcal/mol free energy of folding. The 4.5-6.1 cm

Indexed as

circular dichroismcomputational molecular modelingDuchenne muscular dystrophyensemble of solution structureMD simulationsMT: Oligonucleotides: Therapies and Applicationsoligonucleotides deliveryphosphorodiamidate morpholino oligomersviscosity vs. concentration profiles

Identifiers

PMID40917895
PMCPMC12408397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.